I. Kamaeva

Creation of a collection of blood samples of patients with multiple myeloma

O. Kit, I. Lysenko, A. Sitkovskaya, 2022, Cardiovascular Therapy and Prevention.

The use of immunotherapy for the treatment of refractory forms of Hodgkin lymphoma in real clinical practice.

I. Lysenko, A. Velichko, I. Kamaeva, 2021, South Russian Journal of Cancer.

Systemic chemotherapy for primary cutaneous b-cell lymphoma, leg-type: a case report

I. Lysenko, A. Velichko, I. Kamaeva, 2020, Russian Journal of Oncology.

PRIMARY MEDIASTINAL B-LARGE CELL LYMPHOMA. THE SEARCHING OF OVECOMING OF THE REFRACTORINESS

I. Lysenko, I. Novikova, I. Kamaeva, 2022, Современные проблемы науки и образования (Modern Problems of Science and Education).

Methods of creation of bladder cancer models and their application in preclinical studies (literature review)

A. Goncharova, I. Kamaeva, E. Lukbanova, 2022, Siberian journal of oncology.

EVOLUTION OF DRUG THERAPY FOR CLASSICAL HODGKIN LYMPHOMA

I. Lysenko, I. Kamaeva, N. Samaneva, 2022, South Russian Journal of Cancer.

Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia

I. Lysenko, E. Zlatnik, I. Novikova, 2023, Siberian journal of oncology.

The results of therapy of patients with multiple myeloma in real clinical practice (results of a multicenter study)

K. Gurevich, I. Lysenko, I. Kamaeva, 2024, Meditsinskiy sovet = Medical Council.

PD-1 and LAG-3 as early prognostic markers in the treatment of patients with chronic lymphocytic leukemia

E. Zlatnik, I. Kamaeva, N. Guskova, 2023, Oncohematology.